3 results
Approved WMOWill not start
Use of iron chelation therapy has demonstrated benefits in terms of morbidity and mortality for chronically-transfused thalassemia patients with iron overload. Recent retrospective data (Leitch 2007, Rose 2010, Sanz 2008) suggest that overall…
Approved WMORecruitment stopped
The primary objective of the study is to determine concentration of circulation cytokines na administration of LPS in the presence of iron sucrose (Venofer®), Deferasirox (Exjade®) of placebo.
Approved WMORecruiting
To study the safety and efficacy of deferasirox as treatment of oxidative stress in adult subjects with sickle cell disease.